By Avi Kapoor
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page .
HC Wainwright & Co. cut the price target for Unity Biotechnology, Inc. (NASDAQ
You are viewing a robot-friendly page.Click hereto reload in standard format.